000 | 01889 a2200505 4500 | ||
---|---|---|---|
005 | 20250511230749.0 | ||
264 | 0 | _c19901207 | |
008 | 199012s 0 0 eng d | ||
022 | _a0008-543X | ||
024 | 7 |
_a10.1002/1097-0142(19901115)66:10<2072::aid-cncr2820661006>3.0.co;2-9 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRaney, R B | |
245 | 0 | 0 |
_aPrimary chemotherapy with or without radiation therapy and/or surgery for children with localized sarcoma of the bladder, prostate, vagina, uterus, and cervix. A comparison of the results in Intergroup Rhabdomyosarcoma Studies I and II. _h[electronic resource] |
260 |
_bCancer _cNov 1990 |
||
300 |
_a2072-81 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aClinical Protocols |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
650 | 0 | 4 | _aRemission Induction |
650 | 0 | 4 |
_aRhabdomyosarcoma _xdrug therapy |
650 | 0 | 4 |
_aSarcoma _xdrug therapy |
650 | 0 | 4 |
_aSarcoma, Ewing _xdrug therapy |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aUterine Cervical Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aUterine Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aVaginal Neoplasms _xdrug therapy |
700 | 1 | _aGehan, E A | |
700 | 1 | _aHays, D M | |
700 | 1 | _aTefft, M | |
700 | 1 | _aNewton, W A | |
700 | 1 | _aHaeberlen, V | |
700 | 1 | _aMaurer, H M | |
773 | 0 |
_tCancer _gvol. 66 _gno. 10 _gp. 2072-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19901115)66:10<2072::aid-cncr2820661006>3.0.co;2-9 _zAvailable from publisher's website |
999 |
_c2230883 _d2230883 |